UNSPSC 51112517: Mannomustine hydrochloride

This classification denotes a nitrogen mustard compound C10H22Cl2N2O4.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UOZ2JJZ3I5, chemically known as d-mannitol, 1,6-bis((2-chloroethyl)amino)-1,6-dideoxy-, dihydrochloride, but more generally known as mannomustine hydrochloride, which bears US NIH Compound Identifier 9884430. Most nations, for tariff and trade purposes, schedule mannomustine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, MANNOMUSTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

SMILES: C(CCL)NC[C@H]([C@H]([C@@H]([C@@H](CNCCCL)O)O)O)O.CL.CL.

UNSPSC 51112517 Mannomustine hydrochloride, a Commodity code, covers a specialized chemotherapy agent used in cancer treatment protocols. State and local governments purchase this pharmaceutical through health departments, hospital systems, correctional health services, and public health clinics that provide oncology care or support for incarcerated populations requiring chemotherapy. The drug is procured as a finished pharmaceutical product, typically through standing contracts with pharmaceutical suppliers or via cooperative purchasing agreements that allow multiple jurisdictions to access negotiated pricing. Issuing bodies include state departments of health, county hospital authorities, municipal public health agencies, and state corrections departments.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted solicitations, geographic activity and representative recent RFPs, RFQs, or ITBs cannot be identified from the available data.